Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03065855
Other study ID # ARCTIC
Secondary ID
Status Not yet recruiting
Phase N/A
First received February 23, 2017
Last updated February 23, 2017
Start date February 2017
Est. completion date August 2017

Study information

Verified date January 2017
Source Peking Union Medical College Hospital
Contact XU Lai
Email drxulai@pumch.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Traditionally these catheters are retained for 7 days, because a higher incidence of urinary retention is related to early removal of the urinary catheter. However, recently Enhanced Recovery After Surgery presents that urinary catheters placed via the urethra can be withdrawn 48 hours after colon/rectal surgery in patients receiving epidural pain relief,but there is no clear data on the incidence of urine retention.Longer retaining time of urethral catheter would induce the urinary tract infection while early removal of urethral catheter is considered to develop acute retention of urine due to lack of sensation when the bladder is full. Taking the comfort and mobility for faster rehabilitation of patients into account, the investigators aim at obtain the optimal removal time of urinary catheter after after laparoscopic anterior resection of the rectum


Description:

For a better view to avoid accidental trauma and monitoring kidney function during surgery and in the post-surgery period, patients undergoing abdominal operations will usually have a urinary catheter placed in the bladder before the surgery. Traditionally these catheters are retained for 7 days, because a higher incidence of urinary retention is related to early removal of the urinary catheter. However, recently Enhanced Recovery After Surgery presents that urinary catheters placed via the urethra can be withdrawn 48 hours after colon/rectal surgery in patients receiving epidural pain relief.

Longer retaining time of urethral catheter would induce the urinary tract infection while early removal of urethral catheter is considered to develop acute retention of urine due to lack of sensation when the bladder is full. Taking the comfort and mobility for faster rehabilitation of patients into account, the investigators aim at obtain the optimal removal time of urinary catheter after after laparoscopic anterior resection of the rectum


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 220
Est. completion date August 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Competent to consent to participate in trial

2. Patients with rectal cancer who underwent total or tumor-specific-mesorectal excision with colorectal or colonanal anastomosis

3. Elective surgery

4. ASA classification of 1~3

5. If male, international prostate symptom score <20.

Exclusion Criteria:

1. Combined pelvic surgery(pelvic lymph node dissection, hysterectomy, salpingo-oophorectomy, posterior vaginectomy, cystectomy, ureteral double-J stenting, ureterectomy, ureteroureterostomy, prostatectomy)

2. Postoperative complications with a Dindo grade III or more

3. Known urinary disease(end-stage renal disease, benign prostatic hyperplasia, neurogenic bladder, malignancy)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Early removal group
Participants assigned to the experimental arm will have their urethral catheters removed at 2 days after after laparoscopic anterior resection of the rectum.
Normal removal group
Participants assigned to the control group will have their urethral catheters removed at 7days following surgery, as is standard practice in our institution.

Locations

Country Name City State
China Peking union medical college hospital Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Peking Union Medical College Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Post-operative urinary retention requiring re-catheterisation Development of acute post-operative urinary retention demonstrated by a post-void residual >100mls on bladder ultrasound requiring re-catheterisation within 1 day of removal of urethral catheter in the post-operative period 1 day following urethral catheter removal
Secondary Urinary tract infection Before catheter removal, take a mid-stream urine sample for microscopy and culture. Leucocyte in urine =5/HP for man and =10/HP for woman is defined as bacteruria with urinary irritation or not.A pure culture of a single organism of >100,000 colony forming units will be considered a positive culture. Within 7 days of urethral catheter removal
Secondary Urethrorrhagia take a mid-stream urine sample for Clinical urine tests and RBC=3/HP is defined as urethrorrhagia. Within 7 days of urethral catheter removal
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Completed NCT00409994 - Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer Phase 1/Phase 2
Completed NCT04371198 - Patient-Derived Organoids for Rectal Cancer N/A
Recruiting NCT04916990 - Improving Care for Rural Patients With Solid Tumors N/A
Active, not recruiting NCT05305820 - Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy N/A
Recruiting NCT03699761 - The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection N/A
Recruiting NCT04907643 - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes N/A
Completed NCT03843957 - Effectiveness and Implementation of mPATH-CRC N/A
Completed NCT02423226 - Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer Phase 2
Completed NCT00379743 - Partnership for Healthy Seniors N/A
Completed NCT00509444 - Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial Phase 3
Recruiting NCT06116019 - Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Not yet recruiting NCT06066931 - Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE N/A
Recruiting NCT02738359 - Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening
Completed NCT02997553 - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery Phase 3
Active, not recruiting NCT02458664 - BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer N/A
Withdrawn NCT03257332 - Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
Recruiting NCT05715255 - Adaptive Symptom Self-Management Immunotherapy Study N/A
Completed NCT02641691 - Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Phase 2
Recruiting NCT04405206 - Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer